In the orthotopic tumor model, ZOL significantly increased B220+ B cell infiltration into both sh-NT and sh-CD73 tumors, in comparison to corresponding vehicle + IgG treatment (Figure 6A). This evidence concerns the gene PTPRC and neoplasm.